16-67610962-C-A
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 1P and 6B. PP2BP4_ModerateBS2
The NM_006565.4(CTCF):c.130C>A(p.Gln44Lys) variant causes a missense change. The variant allele was found at a frequency of 0.0000251 in 1,592,416 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_006565.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -5 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152098Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000163 AC: 4AN: 245900Hom.: 0 AF XY: 0.0000226 AC XY: 3AN XY: 132712
GnomAD4 exome AF: 0.0000264 AC: 38AN: 1440318Hom.: 1 Cov.: 31 AF XY: 0.0000309 AC XY: 22AN XY: 712032
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152098Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74312
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
The p.Q44K variant (also known as c.130C>A), located in coding exon 1 of the CTCF gene, results from a C to A substitution at nucleotide position 130. The glutamine at codon 44 is replaced by lysine, an amino acid with similar properties. This amino acid position is well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at